Jubilant Life Sciences 1Q12 1Q Revenues: $209 million (+16%) 1Q Earnings: $17 million (+53%) Comments: CMO revenues accounted for 16% of total revenues ($33 million), while Drug Discovery and Development Services accounted for 5% ($11 million). Life Science Products accounted for 78% of 1Q sales ($163 million), up 19% from the previous year, driven by volume growth and higher pricing. Generic revenues (part of Life Science Products) were up 33% to $29 million....